Simultaneous HPLC determination of remdesivir and dexamethasone in the presence of metformin, sitagliptin, and glimepiride in a synthetic mixture and spiked human plasma
The COVID-19 pandemic has raised many questions regarding the control and therapy of type 2 diabetes and the higher risk of severe disease progression. One of the therapeutic regimens used in moderate and severe cases of COVID-19, endorsed by the World Health Organization, involves the administratio...
Main Authors: | Stanislav Bozhanov, Miglena Smerikarova, Vania Maslarska |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2024-03-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/120463/download/pdf/ |
Similar Items
-
Development and validation of analytical procedure for analysis of Amoxiciline, Metronidazole and Omeprazole, used as anti- Helicobacter pylori agents alone and in mixture
by: Vania Maslarska, et al.
Published: (2023-08-01) -
Deduction of the operable design space of RP-HPLC technique for the simultaneous estimation of metformin, pioglitazone, and glimepiride
by: Aya A. Marie, et al.
Published: (2023-03-01) -
Efficacy, Safety and Treatment Satisfaction of Glimepiride vs Sitagliptin in Combination with Metformin in Type 2 Diabetes Mellitus
by: Subodh Kumar, et al.
Published: (2015-12-01) -
Development of RP-HPLC methods for the analysis of Dexamethasone and Levofloxacin alone and in combinations used in the therapy of Covid-19
by: Lily Peikova, et al.
Published: (2022-12-01) -
Development and validation of a new spectrophotometric method for simultaneous determination of sitagliptin and metformin hydrochloride in tablet pharmaceutical dosage forms using chemometrics technique in comparison with HPLC
by: Maher Ali Almaqtari, et al.
Published: (2023-01-01)